image
Healthcare - Biotechnology - NASDAQ - US
$ 2.89
-16.2 %
$ 237 M
Market Cap
-1.62
P/E
BALANCE SHEET
471 M ASSETS
15.68%
321 M LIABILITIES
69.09%
150 M EQUITY
-31.05%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Sutro Biopharma, Inc.
image
Current Assets 422 M
Cash & Short-Term Investments 376 M
Receivables 36.1 M
Other Current Assets 9.85 M
Non-Current Assets 49.2 M
Long-Term Investments 0
PP&E 44.8 M
Other Non-Current Assets 4.44 M
Current Liabilities 93.7 M
Accounts Payable 9.44 M
Short-Term Debt 16.9 M
Other Current Liabilities 67.4 M
Non-Current Liabilities 227 M
Long-Term Debt 23.2 M
Other Non-Current Liabilities 204 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 69.3 47.3 30.4 206.2 5.0 125.3 22.0 11.6
Short Term Investments 306.4 287.1 167.5 162.0 112.9 79.2 0 35.9
Receivables 36.1 7.1 12.5 5.6 6.3 2.5 1.6 0.6
Inventory 0 (11.7) 1 0 0 1 0 0
Other Current Assets 9.8 11.7 8.1 4.5 8.8 5.9 2.0 1.6
Total Current Assets 421.5 309.5 218.5 378.2 128.6 209.9 25.6 49.7
PP&E 44.8 51.1 51.6 12.9 9.6 10.9 14.0 18.7
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 32.0 68.8 0.9 15.6 15 K 0.2 0.5
Other Long Term Assets 4.4 14.4 2.5 2.1 2.6 2.2 0.9 0.4
Other Assets 0 0 0 0 0 0 0 0
Total Assets 470.7 406.9 341.4 394.1 156.4 223.1 40.8 69.3
LIABILITIES
Accounts Payable 9.4 4.8 6.0 5.5 5.6 3.1 2.9 3.4
Short Term Debt 16.9 21.7 11.4 0 1.0 4.7 14.6 0
Other Current Liabilities 31.6 23.3 18.8 9.4 6.9 7.1 3.8 3.2
Total Current Liabilities 93.7 139.5 41.7 29.6 33.0 36.4 32.0 50.2
Long Term Debt 23.2 33.3 47.0 24.5 8.9 10.0 0 0
Deferred Tax Income 0 0 0 1.3 0.4 0.5 0 (1.2)
Other Liabilities 150.8 0.1 0.1 1.8 0.5 0.6 104.7 104.1
Total Liabilities 321.1 189.9 88.8 62.1 58.6 91.6 149.8 160.2
EQUITY
Common Stock 61 K 58 K 46 K 46 K 23 K 23 K 0 16 K
Retained Earnings (559.4) (452.6) (333.4) (227.9) (195.7) (150.3) (115.0) (95.3)
Other Accumulative Comprehensive Income/Loss 21 K (0.6) (0.3) 0.1 0.2 47 K (0.2) 17 K
Total Equity 149.6 217.0 252.6 332.0 97.8 131.5 (109.0) (90.9)
Total Liabilities and Equity 470.7 406.9 341.4 394.1 156.4 223.1 40.8 69.3
SHARES OUTSTANDING
Common Shares Outstanding 60.2 50.7 46.1 32.6 23.0 5.8 7.0 7.0